Idaho Diabetes and Endocrine Associates, PA

Endocrinology in Boise, Idaho

Practice Details

Address
13909 W. Wainwright Drive
Boise, ID 83713
Geocoded location: 43.6418, -116.3559
Taxonomy
Endocrinology, Diabetes & Metabolism
NPPES Enumeration
Listed with NPPES since 2008
Registered Contact
THEODORE ROOSEVELT, PRESIDENT
NPPES Record Updated
May 2022

About This Practice

This practice is enumerated under Endocrinology, Diabetes & Metabolism. Endocrinologists treat hormonal and metabolic conditions including type 2 diabetes, and frequently prescribe GLP-1 medications such as semaglutide or tirzepatide as part of diabetes or metabolic-syndrome management — though not every endocrinology practice treats obesity as a primary focus, and some see only referred, complex cases.

Locally, this is 1 of 11 Endocrinology, Diabetes & Metabolism practices in Boise carrying this exact taxonomy in our directory.

What to expect at an Endocrinology visit

Endocrinology visits focus on hormonal and metabolic conditions. For a GLP-1-related consult, patients commonly encounter:

  • A review of diabetes, thyroid, or metabolic history and current medications.
  • Lab work such as A1c and a metabolic panel to guide diagnosis and dosing.
  • A discussion of whether a GLP-1 medication fits the treatment goal (diabetes control, weight, or both).
  • Follow-up scheduling to titrate dose and monitor response over time.

This is general guidance for endocrinology practices, not a description of Idaho Diabetes and Endocrine Associates, PA's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 208-389-2213.

GLP-1 access in Boise, Idaho

Adult obesity rate
31.1%
#30 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$199/mo
Typical Idaho telehealth cash price
Medicaid GLP-1 coverage
Diabetes only
Idaho Medicaid, obesity indication

About 31.1% of Idaho adults have obesity (BMI 30+), ranking the state #30 of 50 (CDC BRFSS). Our directory currently lists 39 GLP-1-relevant clinics in Boise. If a cash-pay route makes more sense, compounded semaglutide through Idaho telehealth averages about $199/mo — well below brand-name Wegovy or Zepbound.

Explore more Idaho options on the best Idaho GLP-1 providers page, browse every Boise listing in the Boise clinic directory, or read the Idaho Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Boise

Other Boise listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Idaho addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Idaho telehealth partners:

Featured Partners · Boise

Featured GLP-1 providers serving Boise

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick
    8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  2. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →
  3. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  4. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  5. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  6. Compounded from

    $179/mo

    Save $1,170/mo vs Wegovy
    Get started →

See more Boise options on the Boise clinic directory, our Boise GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Boise obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Idaho Diabetes and Endocrine Associates, PA's specialty taxonomy but not the specific medications it prescribes or its current service menu. Idaho Diabetes and Endocrine Associates, PA is listed under Endocrinology, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 208-389-2213 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Idaho Diabetes and Endocrine Associates, PA's primary specialty on file is Endocrinology.
Idaho Diabetes and Endocrine Associates, PA is located at 13909 W. Wainwright Drive, Boise, ID 83713. The phone number listed in the registry is 208-389-2213. Its full record is public in the CMS National Provider registry under NPI 1790960961.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Idaho Diabetes and Endocrine Associates, PA is currently accepting new patients. Call the practice at 208-389-2213 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.